Novartis, aiming to clean up its rep, sets aside $700M for kickback settlement

With nearly decade-old bribery charges hanging over its head, Novartis has been eager to wriggle out of U.S. prosecutors’ crosshairs. Now, a settlement appears to be in the works—and it could cost Novartis close to a billion dollars.